# Consumers Bancorp Inc: financial statements, quarterly

CBKM · OTC · CIK 1006830 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/cbkm.md) · [Financials](/companies/cbkm/financials.md) · [Filings](/companies/cbkm/filings.md) · [Insiders](/companies/cbkm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbkm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [3,581](/filings/0001437749-23-031192.md) | [4,224](/filings/0001437749-24-003786.md) | [4,580](/filings/0001437749-24-014990.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [517](/filings/0001437749-24-034178.md) | [435](/filings/0001437749-25-003134.md) | [435](/filings/0001437749-25-015399.md) | [458 d](/filings/0001437749-25-028445.md) | [480](/filings/0001437749-25-033730.md) | [488](/filings/0001437749-26-003344.md) | [274](/filings/0001437749-26-015787.md) | [415 d](/filings/0001437749-26-030039.md) | [477](/filings/0001437749-25-033730.md) | [495](/filings/0001437749-26-003344.md) | [524](/filings/0001437749-26-015787.md) | [517 d](/filings/0001437749-26-030039.md) |
| Net income | $k | [2,410](/filings/0001437749-24-034178.md) | [2,015](/filings/0001437749-25-003134.md) | [2,052](/filings/0001437749-25-015399.md) | [2,103 d](/filings/0001437749-25-028445.md) | [2,236](/filings/0001437749-25-033730.md) | [2,287](/filings/0001437749-26-003344.md) | [1,851](/filings/0001437749-26-015787.md) | [2,293 d](/filings/0001437749-26-030039.md) | [2,634](/filings/0001437749-25-033730.md) | [2,755](/filings/0001437749-26-003344.md) | [2,817](/filings/0001437749-26-015787.md) | [2,958 d](/filings/0001437749-26-030039.md) |
| Diluted EPS | $ per share | [0.78](/filings/0001437749-24-034178.md) | [0.65](/filings/0001437749-25-003134.md) | [0.66](/filings/0001437749-25-015399.md) | not reported | [0.72](/filings/0001437749-25-033730.md) | [0.73](/filings/0001437749-26-003344.md) | [0.59](/filings/0001437749-26-015787.md) | not reported | [0.84](/filings/0001437749-25-033730.md) | [0.87](/filings/0001437749-26-003344.md) | [0.90](/filings/0001437749-26-015787.md) | not reported |
| Basic EPS | $ per share | [0.78](/filings/0001437749-24-034178.md) | [0.65](/filings/0001437749-25-003134.md) | [0.66](/filings/0001437749-25-015399.md) | not reported | [0.72](/filings/0001437749-25-033730.md) | [0.73](/filings/0001437749-26-003344.md) | [0.59](/filings/0001437749-26-015787.md) | not reported | [0.84](/filings/0001437749-25-033730.md) | [0.87](/filings/0001437749-26-003344.md) | [0.90](/filings/0001437749-26-015787.md) | not reported |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,058](/filings/0001437749-23-031192.md) | [1,081](/filings/0001437749-24-003786.md) | [1,091](/filings/0001437749-24-014990.md) | [1,097](/filings/0001437749-25-028445.md) | [1,124](/filings/0001437749-24-034178.md) | [1,111](/filings/0001437749-25-003134.md) | [1,134](/filings/0001437749-25-015399.md) | [1,165](/filings/0001437749-26-030039.md) | [1,188](/filings/0001437749-25-033730.md) | [1,213](/filings/0001437749-26-003344.md) | [1,238](/filings/0001437749-26-015787.md) | [1,280](/filings/0001437749-26-030039.md) |
| Total liabilities | $m | [1,008](/filings/0001437749-23-031192.md) | [1,018](/filings/0001437749-24-003786.md) | [1,029](/filings/0001437749-24-014990.md) | [1,033](/filings/0001437749-25-028445.md) | [1,051](/filings/0001437749-24-034178.md) | [1,042](/filings/0001437749-25-003134.md) | [1,060](/filings/0001437749-25-015399.md) | [1,089](/filings/0001437749-26-030039.md) | [1,106](/filings/0001437749-25-033730.md) | [1,126](/filings/0001437749-26-003344.md) | [1,151](/filings/0001437749-26-015787.md) | [1,190](/filings/0001437749-26-030039.md) |
| Short-term borrowings | $m | [21.9](/filings/0001437749-23-031192.md) | [25.4](/filings/0001437749-24-003786.md) | [29.0](/filings/0001437749-24-014990.md) | [30.0](/filings/0001437749-25-028445.md) | [27.1](/filings/0001437749-24-034178.md) | [20.9](/filings/0001437749-25-003134.md) | [16.5](/filings/0001437749-25-015399.md) | [15.5](/filings/0001437749-26-030039.md) | [19.8](/filings/0001437749-25-033730.md) | [20.4](/filings/0001437749-26-003344.md) | [21.7](/filings/0001437749-26-015787.md) | [29.2](/filings/0001437749-26-030039.md) |
| Shareholders' equity | $m | [49.6](/filings/0001437749-25-003134.md) | [63.5](/filings/0001437749-25-015399.md) | [62.1](/filings/0001437749-25-015399.md) | [63.7](/filings/0001437749-26-030039.md) | [73.3](/filings/0001437749-26-003344.md) | [69.5](/filings/0001437749-26-015787.md) | [73.5](/filings/0001437749-26-015787.md) | [76.3](/filings/0001437749-26-030039.md) | [81.6](/filings/0001437749-26-003344.md) | [86.1](/filings/0001437749-26-015787.md) | [86.9](/filings/0001437749-26-015787.md) | [89.9](/filings/0001437749-26-030039.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,654](/filings/0001437749-24-034178.md) | [2,179 d](/filings/0001437749-25-003134.md) | [1,899 d](/filings/0001437749-25-015399.md) | [1,644 d](/filings/0001437749-25-028445.md) | [1,142](/filings/0001437749-25-033730.md) | [3,214 d](/filings/0001437749-26-003344.md) | [2,038 d](/filings/0001437749-26-015787.md) | [1,540 d](/filings/0001437749-26-030039.md) | [2,535](/filings/0001437749-25-033730.md) | [3,476 d](/filings/0001437749-26-003344.md) | [1,600 d](/filings/0001437749-26-015787.md) | [3,578 d](/filings/0001437749-26-030039.md) |
| Capital expenditure | $k | [332](/filings/0001437749-24-034178.md) | [214 d](/filings/0001437749-25-003134.md) | [265 d](/filings/0001437749-25-015399.md) | [172 d](/filings/0001437749-25-028445.md) | [1,021](/filings/0001437749-25-033730.md) | [1,314 d](/filings/0001437749-26-003344.md) | [412 d](/filings/0001437749-26-015787.md) | [324 d](/filings/0001437749-26-030039.md) | [319](/filings/0001437749-25-033730.md) | [227 d](/filings/0001437749-26-003344.md) | [836 d](/filings/0001437749-26-015787.md) | [253 d](/filings/0001437749-26-030039.md) |
| Dividends paid | $k | [560](/filings/0001437749-24-034178.md) | [561 d](/filings/0001437749-25-003134.md) | [563 d](/filings/0001437749-25-015399.md) | [562 d](/filings/0001437749-25-028445.md) | [594](/filings/0001437749-25-033730.md) | [596 d](/filings/0001437749-26-003344.md) | [595 d](/filings/0001437749-26-015787.md) | [598 d](/filings/0001437749-26-030039.md) | [661](/filings/0001437749-25-033730.md) | [661 d](/filings/0001437749-26-003344.md) | [661 d](/filings/0001437749-26-015787.md) | [661 d](/filings/0001437749-26-030039.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,048](/filings/0001437749-23-031192.md) | [3,077](/filings/0001437749-24-003786.md) | [3,080](/filings/0001437749-24-014990.md) | [3,093](/filings/0001437749-24-034178.md) | [3,107](/filings/0001437749-25-003134.md) | [3,116](/filings/0001437749-25-015399.md) | [3,120](/filings/0001437749-25-033730.md) | [3,133](/filings/0001437749-26-003344.md) | [3,139](/filings/0001437749-26-015787.md) | [3,143](/filings/0001437749-25-033730.md) | [3,149](/filings/0001437749-26-003344.md) | [3,147](/filings/0001437749-26-015787.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,156,730 at 2026-09-10, from the cover of the [10-K filed 2026-09-10](/filings/0001437749-26-030039.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.